HARRIS TODD (Chief Executive Officer) sold 0.8% of their position (11.75K shares) of TYRA BIOSCIENCES, INC. on the open market
Open‑market sale worth $283.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/25/2024ACC: 0000950170-24-109410
DirectorOfficer· Chief Executive Officer
Since Sep 2021
-11.75K
Net shares
Net seller
$283.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
11.75K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−10.09K
Price / share
$24.13
Trade value
$243.48K
% of position
0.7%
9/23/2024
1.49M→1.48M
Common Stock
Direct
Shares
−1.05K
Price / share
$24.02
Trade value
$25.34K
% of position
0.1%
9/24/2024
1.48M→1.48M
Common Stock
Direct
Shares
−600.00
Price / share
$24.01
Trade value
$14.41K
% of position
0.0%
9/25/2024
1.48M→1.48M
Total
Net shares
−11.75K
Net value
-$283.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/23/2024 | S · Sale | −10.09K | $24.13 | $243.48K | 0.7% | 1.49M | 1.48M |
| Common Stock Direct | 9/24/2024 | S · Sale | −1.05K | $24.02 | $25.34K | 0.1% | 1.48M | 1.48M |
| Common Stock Direct | 9/25/2024 | S · Sale | −600.00 | $24.01 | $14.41K | 0.0% | 1.48M | 1.48M |
| Total | −11.75K | -$283.22K | ||||||
Derivative Transactions0
No derivative transactions reported